Skip to main content

1427 5 Pill - yellow round

Generic Name: dapagliflozin

Pill with imprint 1427 5 is Yellow, Round and has been identified as Farxiga 5 mg. It is supplied by Bristol-Myers Squibb Company.

Farxiga is used in the treatment of Chronic Kidney Disease; Heart Failure; Diabetes, Type 2 and belongs to the drug class SGLT-2 inhibitors. Risk cannot be ruled out during pregnancy. Farxiga 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 1427 5

Farxiga 5 mg 1427 5 Front
Farxiga 5 mg 1427 5 Back
Farxiga 5 mg 1427 5


Generic Name
1427 5
5 mg
Prescription only
Drug Class
SGLT-2 inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bristol-Myers Squibb Company
Inactive Ingredients
microcrystalline cellulose, lactose anhydrous, crospovidone, silicon dioxide, magnesium stearate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00003-1427 (Discontinued)
00310-6205 AstraZeneca

Get help with Imprint Code FAQs.

Related images for "1427 5"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.